[Study of treatment of refractory rheumatoid arthritis with autologous peripheral blood stem cell transplantation]

Zhonghua Yi Xue Za Zhi. 2002 Jun 10;82(11):748-51.
[Article in Chinese]

Abstract

Objective: To explore the efficacy, safety and immune reconstitution of autologous peripheral blood stem cell transplantation (APBSCT) using T cell depleted grafts in the treatment of refractory rheumatoid arthritis (RA).

Methods: One patient with RA was treated with APBSCT. The method included mobilization with 2 g/m(2) cyclophosphamide (CY) and subcutaneous injection of granulocyte-colony stimulating factor (G-CSF). Immunomagnetic selection of CD34(+) cells from the leukapheresis products was performed to deplete potentially autoreative lymphocytes. The conditioning regimen consisted of intravenous administration of 2 g/m2 CY and 90 mg/kg ATG, with subsequent reinfusion of the graft. G-CSF was used to help hematopoietic and immunologic reconstitution. Phenotype of the peripheral blood lymphocytes was analyzed to observe the immunologic reconstitution after transplantation.

Results: The patient completed the mobilization, conditioning regimen and transplantation successfully. The hematologic recovery was rapid and the patient achieved clinical remission. The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) decreased to normal level and the rheumatoid factor (RF) turned negative after a follow-up of 12 months. An ongoing course of immunologic reconstitution was observed.

Conclusion: APBSCT is effective and safey for refractory RA, and can induce improvement of disease activity. The course of immunologic reconstitution after transplantation remains to be observed in long-term followup.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / therapy*
  • Blood Sedimentation
  • C-Reactive Protein / metabolism
  • CD4 Antigens / analysis
  • CD4-CD8 Ratio
  • CD8 Antigens / analysis
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Remission Induction
  • Rheumatoid Factor / blood
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • CD4 Antigens
  • CD8 Antigens
  • C-Reactive Protein
  • Rheumatoid Factor